DDO-2728

N/A

Report date: 2023/11/24 15:28:22
NME

Base Information

Drug NameDDO-2728
Drug Alias NameDDO-2728
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA demethylase ALKBH5 inhibitors
TargetsRNA demethylase ALKBH5
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A